Variant report
Variant | esv2752540 |
---|---|
Chromosome Location | chr8:6129102-6144912 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6139049..6141857-chr8:6147372..6149538,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567849202 | chr8:6132012-6132013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528901590 | chr8:6132022-6132023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181781495 | chr8:6132023-6132024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565773983 | chr8:6132067-6132068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150388015 | chr8:6132068-6132069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73192634 | chr8:6132069-6132070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs571153715 | chr8:6132087-6132088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536827691 | chr8:6132090-6132091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557254348 | chr8:6132135-6132136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144988264 | chr8:6132139-6132140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536671388 | chr8:6132173-6132174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187569754 | chr8:6132180-6132181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573295612 | chr8:6132190-6132191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545566508 | chr8:6132192-6132193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565357072 | chr8:6132230-6132231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563688017 | chr8:6132250-6132251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575945008 | chr8:6132262-6132263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544784679 | chr8:6132300-6132301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148232808 | chr8:6132320-6132321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561649809 | chr8:6132326-6132327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530286976 | chr8:6132351-6132352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536258150 | chr8:6132353-6132354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112644001 | chr8:6132361-6132362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75091977 | chr8:6132391-6132392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528070022 | chr8:6132415-6132416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372217532 | chr8:6132426-6132427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117688018 | chr8:6132476-6132477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536862667 | chr8:6132506-6132507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114299394 | chr8:6132508-6132509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs57084818 | chr8:6132519-6132520 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs536116440 | chr8:6132549-6132550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190703600 | chr8:6132560-6132561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573302261 | chr8:6132570-6132571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539021068 | chr8:6132595-6132596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112276107 | chr8:6132608-6132609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575782955 | chr8:6132627-6132628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544795196 | chr8:6132641-6132642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561287732 | chr8:6132642-6132643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574970470 | chr8:6132662-6132663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540614368 | chr8:6132673-6132674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61462536 | chr8:6132677-6132678 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs534821698 | chr8:6132693-6132694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528108070 | chr8:6132706-6132707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7843093 | chr8:6132709-6132710 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs564658272 | chr8:6132712-6132713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548431861 | chr8:6132719-6132720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149094057 | chr8:6132724-6132725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183003793 | chr8:6132764-6132765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371689483 | chr8:6132782-6132783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35222608 | chr8:6132784-6132785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6132000-6132800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr8:6132200-6132800 | Enhancers | Spleen | Spleen |
3 | chr8:6132200-6133600 | Enhancers | Pancreas | Pancrea |
4 | chr8:6132800-6134800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr8:6132800-6149000 | Weak transcription | Spleen | Spleen |
6 | chr8:6134800-6135000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr8:6138400-6141200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:6140200-6140400 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
9 | chr8:6140800-6141000 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
10 | chr8:6141200-6141400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr8:6141400-6144400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr8:6144400-6144600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr8:6144600-6147200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |